Association between antiviral prophylaxis and cytomegalovirus and Epstein-Barr virus DNAemia in pediatric recipients of allogeneic hematopoietic stem cell transplant

Authors

Ndeye Soukeyna Diop, Université de Montréal
Pascal Roland Enok Bonong, Université de Montréal
Chantal Buteau, Université de Montréal
Michel Duval, Université de Montréal
Jacques Lacroix, Université de Montréal
Louise Laporte, CHU Sainte-Justine Research Centre
Marisa Tucci, Université de Montréal
Nancy Robitaille, Université de Montréal
Philip C Spinella, Washington University School of Medicine in St. Louis
Geoffrey Cuvelier, University of Manitoba
Suzanne M Vercauteren, University of British Colombia
Victor Lewis, University of Calgary
Caroline Alfieri, Université de Montréal
Helen Trottier, Université de Montréal

Journal

Vaccines (Basel)

Publication Date

2021

Volume

9

Issue

6

First Page

610

Document Type

Open Access Publication

DOI

10.3390/vaccines9060610

Rights and Permissions

Diop NS, Enok Bonong PR, Buteau C, et al. Association between Antiviral Prophylaxis and Cytomegalovirus and Epstein-Barr Virus DNAemia in Pediatric Recipients of Allogeneic Hematopoietic Stem Cell Transplant. Vaccines (Basel). 2021;9(6):610. Published 2021 Jun 7. doi:10.3390/vaccines9060610

Recommended Citation

Diop, Ndeye Soukeyna; Enok Bonong, Pascal Roland; Buteau, Chantal; Duval, Michel; Lacroix, Jacques; Laporte, Louise; Tucci, Marisa; Robitaille, Nancy; Spinella, Philip C; Cuvelier, Geoffrey; Vercauteren, Suzanne M; Lewis, Victor; Alfieri, Caroline; and Trottier, Helen, "Association between antiviral prophylaxis and cytomegalovirus and Epstein-Barr virus DNAemia in pediatric recipients of allogeneic hematopoietic stem cell transplant." Vaccines (Basel). 9, 6. 610 (2021).
https://digitalcommons.wustl.edu/open_access_pubs/10458